Clinical Trials Directory

Trials / Terminated

TerminatedNCT01229592

Ethanol in the Prevention of Central Venous Catheter Infections

Clinical Study of Ethanol Lock-therapy in the Prevention of Non-tunnelled, Short Term Central Venous Catheter Associated Infections

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Hospital General Universitario Gregorio Marañon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In recent years, several new methods for treatment of catheter-related bloodstream infections (CRBSI) such as antibiotic or antiseptic lock-therapy have been developed with variable success \[1-10\]. Long-term tunnelled central venous catheters provide a reliable access for administration of chemotherapy, parenteral nutrition or haemodialysis. However, they are not free of complications such as bacteremia. The need to preserve these intra-vascular devices as long as is possible in patients in whom conventional treatment was failed makes emerge antibiotic lock-technique. Ethanol lock-therapy was demonstrate her utility in this cases. But no study has yet been published using the ethanol lock-therapy as a prophylactic therapy in catheter related infections, neither her application in short-term CVCs. Objectives: To investigate the value of a ethanol-lock solution in the prophylaxis of non-tunnelled short-term CVC related infections in a heart post-surgical intensive care unit (HPSICU). Methods: An academic, prospective, randomized and controlled clinical trial is proposed. Patients at HPSICU who have a CVC more than 48 h will be randomized in two arms (ethanol-lock or control group with conventional measurements such as anticoagulants). In the follow-up period, we will register all necessary data to evaluate the end-points of study (CBRSI rate, catheter colonization rate, hospital stay, antimicrobial consume and adverse events due to ethanol).

Conditions

Interventions

TypeNameDescription
DRUGEthanolEvery three day lock using Ethanol(70%)in all the lumen(1ml/per lumen) of the Catheter
DRUGHeparineEvery three day lock using Heparin(Fibrilin TM) 3ml in all the lumen of the Catheter

Timeline

Start date
2009-12-01
Primary completion
2012-02-01
Completion
2012-02-01
First posted
2010-10-28
Last updated
2012-07-17

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01229592. Inclusion in this directory is not an endorsement.

Ethanol in the Prevention of Central Venous Catheter Infections (NCT01229592) · Clinical Trials Directory